These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1558092)

  • 1. Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-alpha therapy for metastatic carcinoma: a case report.
    Sauter NP; Atkins MB; Mier JW; Lechan RM
    Am J Med; 1992 Apr; 92(4):441-4. PubMed ID: 1558092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary hypothyroidism associated with interleukin-2 and interferon alpha-2 therapy of melanoma and renal carcinoma.
    Scalzo S; Gengaro A; Boccoli G; Masciulli R; Giannella G; Salvo G; Marolla P; Carlini P; Massimini G; Holdener EE
    Eur J Cancer; 1990; 26(11-12):1152-6. PubMed ID: 2149997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible primary hypothyroidism with blocking or stimulating type TSH binding inhibitor immunoglobulin following recombinant interferon-alpha therapy in patients with pre-existing thyroid disorders.
    Chen FQ; Okamura K; Sato K; Kuroda T; Mizokami T; Fujikawa M; Tsuji H; Okamura S; Fujishima M
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):207-14. PubMed ID: 8881454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperdynamic hemodynamics following high-dose interleukin 2-interferon alpha therapy in patients with metastatic renal cell carcinoma. Immunotherapy as a clinical sepsis model?].
    Finck-Seelen ; Lampert R; Brandt L
    Anaesthesist; 1996 Dec; 45(12):1171-8. PubMed ID: 9065251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of hypothyroidism associated with alpha-interferon therapy.
    Taniguchi Y; Murakami T; Nakanishi K; Tamai M; Matsuura B; Masumoto T; Onji M; Tajiri J; Noguchi S; Ohta Y
    Intern Med; 1992 Mar; 31(3):373-6. PubMed ID: 1611189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune thyroiditis following interleukin-2 and LAK cell therapy for metastatic renal cell carcinoma: correlation with tumor regression.
    Besana C; Sabbadini MG; Corti C; Di Lucca G; Foppoli M; Marcatti M; Heltai S; Rugarli C
    Tumori; 1991 Aug; 77(4):339-42. PubMed ID: 1746057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: silent thyroiditis developed during alpha-interferon therapy.
    Kamikubo K; Takami R; Suwa T; Kawase Y; Shiroko J; Kametani M; Tokimitsu N; Sakata S
    Am J Med Sci; 1993 Sep; 306(3):174-6. PubMed ID: 8128980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroiditis after treatment with interleukin-2 and interferon alpha-2a.
    Pichert G; Jost LM; Zöbeli L; Odermatt B; Pedia G; Stahel RA
    Br J Cancer; 1990 Jul; 62(1):100-4. PubMed ID: 2390468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment.
    Weijl NI; Van der Harst D; Brand A; Kooy Y; Van Luxemburg S; Schroder J; Lentjes E; Van Rood JJ; Cleton FJ; Osanto S
    J Clin Oncol; 1993 Jul; 11(7):1376-83. PubMed ID: 8315436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunitinib-induced thyrotoxicosis followed by persistent hypothyroidism with shrinkage of thyroid volume.
    Sakurai K; Fukazawa H; Arihara Z; Yoshida K
    Tohoku J Exp Med; 2010 Sep; 222(1):39-44. PubMed ID: 20814176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon.
    Kodama T; Katabami S; Kamijo K; Katanuma A; Yamashita K; Azuma N; Tamaki T; Yachi A
    J Gastroenterol; 1994 Jun; 29(3):289-92. PubMed ID: 8061797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer.
    Franzke A; Peest D; Probst-Kepper M; Buer J; Kirchner GI; Brabant G; Kirchner H; Ganser A; Atzpodien J
    J Clin Oncol; 1999 Feb; 17(2):529-33. PubMed ID: 10080596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid function abnormalities associated with the chronic outpatient administration of recombinant interleukin-2 and recombinant interferon-alpha.
    Jacobs EL; Clare-Salzler MJ; Chopra IJ; Figlin RA
    J Immunother (1991); 1991 Dec; 10(6):448-55. PubMed ID: 1768679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient thyrotoxicosis occurred after cessation of steroid therapy in a patient with autoimmune thyroiditis and rheumatoid arthritis.
    Maruyama H; Kato M; Mizuno O; Kataoka K; Matsuki S
    Endocrinol Jpn; 1982 Oct; 29(5):583-8. PubMed ID: 6897816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypothyroidism followed by interferon-alpha as adjuvant therapy of renal cell carcinoma: a case report].
    Ueda H; Ishikawa A; Itoh S; Kusaka M; Azuma H; Suzuki T; Takasaki N; Isurugi K; Ueno N; Demura A
    Hinyokika Kiyo; 1992 Oct; 38(10):1165-9. PubMed ID: 1481777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.
    Bergmann L; Fenchel K; Weidmann E; Enzinger HM; Jahn B; Jonas D; Mitrou PS
    Cancer; 1993 Sep; 72(5):1733-42. PubMed ID: 8348502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hashimoto's thyroiditis presenting as acute painful thyroiditis and as a manifestation of an immune reconstitution inflammatory syndrome in a human immunodeficiency virus-seropositive patient.
    Visser R; de Mast Q; Netea-Maier RT; van der Ven AJ
    Thyroid; 2012 Aug; 22(8):853-5. PubMed ID: 22784301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute thyroid dysfunction (thyroiditis) after therapy with interleukin-2.
    Vassilopoulou-Sellin R; Sella A; Dexeus FH; Theriault RL; Pololoff DA
    Horm Metab Res; 1992 Sep; 24(9):434-8. PubMed ID: 1427615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous intravenous interleukin-2 infusion and subcutaneous interferon-alpha in metastatic renal cell carcinoma.
    Fosså SD; Aune H; Baggerud E; Granerud T; Heilo A; Theodorsen L
    Eur J Cancer; 1993; 29A(9):1313-5. PubMed ID: 8343275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.